Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis.

NCT00360386 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00360386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00360386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis.
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
February 28, 2005
Enrollment
110
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ischemia